Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCloudtag Inc Regulatory News (CTAG)

  • There is currently no data for CTAG

Operations Update

29 Sep 2015 07:01

RNS Number : 4744A
CloudTag Inc.
29 September 2015
 

29 September 2015

CloudTag Inc.

('CloudTag' or 'the Company')

 

Operations Update, Warrant Agreement, Issue of Equity and Subscription of Loan Notes

 

Operations Update

CloudTag (CTAG:LN), the company that brings personal monitoring to the health, wellbeing and fitness markets, is pleased to announce that its long term strategic shareholder and software developer Preciousbluedot Ltd has successfully integrated Adience's proprietary, cutting edge user profiling technology into the MyCloudTag App. This integration will allow CloudTag to create rich and accurate profiles of its users through deep machine learning algorithms based on more than 1,000 different data points in the App.

 

Warrant Agreement

CloudTag has agreed to settle historic fees due to Preciousbluedot Ltd. through the issuance of warrants over 11,433,334 ordinary shares at a strike price of 3.0 pence per share. The warrants vest immediately and are exercisable at any time until the tenth anniversary of the date of grant, being 28 September 2025.

 

Issue of Equity

The Company has issued, in aggregate, 799,629 new ordinary shares in settlement of fees due to a director and an employee ("Fee Shares"), comprising:

 

· 560,000 new ordinary shares at an average price of 2.5 pence per share in settlement of director's fees due to Amit Ben-Haim, CEO of the Company, under the terms of his employment contract. Following this issue of equity, Amit Ben-Haim is interested in 8,215,165 shares in the Company, representing 4.01 per cent. of the Company's so enlarged issued share capital; and

 

· 239,629 new ordinary shares at an average price of 2.51 pence per share in settlement of fees due to an employee of the Company under the terms of his employment contract.

 

Application will be made for the admission of the Fee Shares to trading on AIM and it is expected that dealings in these shares will commence on or around 5 October 2015.

 

Following the issue of the Fee Shares, the total number of ordinary shares in issue is 205,002,214. This number may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company.

 

Subscription of Loan Notes

CloudTag has entered into a subscription agreement with a new investor in respect of the issue of £150,000 unsecured convertible loan notes due in September 2016 ("Loan Notes"). These Loan Notes may be converted at any time and are convertible into ordinary shares in the Company at 2.5 pence per share if converted by the holder, or at 2.5 pence per 1.5 shares if converted early at the Company's option. The Loan Notes carry nil interest until 28 March 2016 and thereafter carry interest at 8% per annum.

 

Funds raised from the issue of the Loan Notes will be used for general working capital purposes. The Company is in discussions with a number of third parties with regard to additional funding which may be required to fund the Company through to planned launch of its wearable technology in early 2016 which is in line with the circular published by the Company on 4 December 2014.

 

 

Enquiries

 

CloudTag Inc.

Amit Ben-Haim / Jamie Bligh 

 

+1 345 949 45 44

contact@cloudtag.com

Cairn Financial Advisers LLP (Nominated Adviser)

Avi Robinson / Tony Rawlinson

+44 (0) 20 7148 7900

Whitman Howard Limited (Broker)

Niall Devins / Ranald McGregor-Smith

+44 (0) 20 7659 1234

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLPMBTMBATTLA
Date   Source Headline
5th Sep 201611:00 amRNSSecond Price Monitoring Extn
5th Sep 20169:05 amRNSSecond Price Monitoring Extn
5th Sep 20169:00 amRNSPrice Monitoring Extension
2nd Sep 20164:40 pmRNSSecond Price Monitoring Extn
2nd Sep 20164:35 pmRNSPrice Monitoring Extension
2nd Sep 20164:02 pmRNSMovement in Share Price and Update
16th Aug 201611:16 amRNSHolding(s) in Company
10th Aug 20167:00 amRNSFundraise of £580,000
8th Aug 20167:00 amRNSBinding Heads of Terms Signed with US Partner
5th Aug 20161:28 pmRNSCorrection: Holding(s) in Company
4th Aug 20164:08 pmRNSHolding(s) in Company
1st Aug 20167:00 amRNSAppointment of Chief Creative Officer
18th Jul 20165:13 pmRNSHolding(s) in Company
14th Jul 201611:32 amRNSHolding(s) in Company
14th Jul 20167:00 amRNSFundraise of £800,000
12th Jul 20167:00 amRNSIssue of Equity
6th Jul 20167:00 amRNSGrant of Options and Warrants
5th Jul 20164:40 pmRNSSecond Price Monitoring Extn
5th Jul 20164:35 pmRNSPrice Monitoring Extension
1st Jul 20164:10 pmRNSHolding(s) in Company
28th Jun 20167:00 amRNSHalf-year Report
22nd Jun 20161:10 pmRNSHolding(s) in Company
16th Jun 20167:00 amRNSOperational Update & Subscription for £470,000
15th Jun 20164:21 pmRNSHolding(s) in Company
9th Jun 20167:00 amRNSCommercial Update and Subscription
31st May 201610:07 amRNSMovement in Share Price
10th May 201610:06 amRNSHolding(s) in Company
3rd May 20167:00 amRNSFundraising £50,000 & Conversion of Loan Notes
29th Apr 20164:48 pmRNSIssue of Equity
26th Apr 20164:03 pmRNSResult of AGM
12th Apr 20163:59 pmRNSCorrection: Fundraise of £171,430
11th Apr 20167:00 amRNSFundraise of £171,430
7th Apr 20164:58 pmRNSHolding(s) in Company
5th Apr 20166:01 pmRNSFundraise of £60,000
31st Mar 20167:00 amRNSHolding(s) in Company
30th Mar 20165:23 pmRNSPosting of Annual Report
30th Mar 20167:00 amRNSDirector/PDMR Shareholding
24th Mar 20167:00 amRNSFundraise of £112,000
23rd Mar 20167:00 amRNSFinal Results
21st Mar 20167:00 amRNSFundraise of £225,400
16th Mar 201611:03 amRNSFundraise of £228,000
16th Mar 20169:28 amRNSHolding(s) in Company
7th Mar 20167:00 amRNSFundraise of £65,000
29th Feb 20164:19 pmRNS£215,000 Fundraising
25th Jan 20167:00 amRNSUS$5.2 Million Distribution Agreement
22nd Jan 20167:00 amRNSISPO Exhibition
21st Jan 20167:00 amRNS£250,000 Fundraising
15th Jan 20167:00 amRNSOperational Update & Convertible Loan Facility
6th Jan 20168:03 amRNSFirst Product Launch
31st Dec 20157:00 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.